Kala Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Kala Pharmaceuticals Inc cash flow-to-debt ratio. Kala Pharmaceuticals Inc (KALA) has a Cash Flow-to-Debt Ratio of -1.83x as of March 2026, meaning its operating cash flow of $-4.56 Million could theoretically repay -2% of its total liabilities ($2.49 Million) in one year. See KALA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kala Pharmaceuticals Inc (2013–2025)
Cash flow-to-debt ratio of Kala Pharmaceuticals Inc from 2013 to 2025. Historical debt coverage capacity for Kala Pharmaceuticals Inc across 13 annual periods. Check KALA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Kala Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
Kala Pharmaceuticals Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Kala Pharmaceuticals Inc. For the full cash flow conversion analysis, see Kala Pharmaceuticals Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -12.83x | $-31.99 Million | $2.49 Million | ▼ -1783.8% |
| 2024 | -0.68x | $-29.38 Million | $43.15 Million | ▼ -18.1% |
| 2023 | -0.58x | $-27.93 Million | $48.45 Million | ▲ +50.4% |
| 2022 | -1.16x | $-78.91 Million | $67.85 Million | ▼ -31.8% |
| 2021 | -0.88x | $-108.23 Million | $122.62 Million | ▼ -18.4% |
| 2020 | -0.75x | $-90.69 Million | $121.61 Million | ▼ -0.2% |
| 2019 | -0.74x | $-92.72 Million | $124.63 Million | ▼ -59.4% |
| 2018 | -0.47x | $-54.12 Million | $115.98 Million | ▲ +63.8% |
| 2017 | -1.29x | $-34.10 Million | $26.45 Million | ▼ -532.0% |
| 2016 | -0.20x | $-27.35 Million | $134.09 Million | ▲ +80.8% |
| 2015 | -1.06x | $-15.09 Million | $14.24 Million | ▲ +41.6% |
| 2014 | -1.82x | $-15.36 Million | $8.46 Million | ▼ -15.1% |
| 2013 | -1.58x | $-10.84 Million | $6.87 Million | — |